ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Pearl Granted U.S. Patent for Dental Practice Data Analysis AI Technology

Patent grants exclusive rights to the AI systems behind Pearl’s pioneering Practice Intelligence® clinical performance platform

Pearl, the global leader in dental AI solutions, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,776,677 entitled “Computer Vision-Based Analysis Of Provider Data” for the exclusive rights to the computer vision system at the core of its pioneering clinical performance software, Practice Intelligence®.

This patent covers the machine learning techniques used to analyze data associated with one or more dental practices to identify missed treatment opportunities, future treatment opportunities, or provider performance metrics. Practice Intelligence® analyzes AI-detected evidence in patient radiographs in conjunction with patient treatment data to identify office and practitioner-specific patterns. Pearl’s patented system then synthesizes its findings into actionable patient health and clinical performance insights, helping to facilitate superior oral healthcare outcomes for patients, strong financial outcomes for practices, and a more productive dental care workflow.

“Practice Intelligence equips dental practices around the world with clinical performance insights essential for increasing operational efficiency and boosting practice growth,” said Ophir Tanz, Founder and CEO of Pearl. “With this patent, Pearl is expanding its portfolio of exclusive intellectual property, reinforcing the technological advantages and effectiveness of our dental AI solutions.”

This latest patent increases Pearl’s total number of U.S. patents to 12. Earlier this year, Pearl was issued a patent for its “Systems and Methods for Automated Medical Image Analysis, which grants Pearl the exclusive rights to the computer system technology supporting the application programming interface (API) of its chairside AI disease detection software, Second Opinion®. Other recent patents include “Computer Vision-Based Claims Processing,” “Systems and Methods for Insurance Fraud Detection (2021)”, “Systems and Methods For Insurance Fraud Detection (2020)” and “Systems and Methods for Automated Medical Image Annotation.”

About Pearl

Pearl is leading the global dental AI revolution with groundbreaking computer vision solutions that elevate efficiency, accuracy, and the standard of care in dentistry. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. To request a demo, please visit hellopearl.com/demo.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.